Auto-antibodies against type I IFNs are associated with severe COVID-19 pneumonia

por Zhou, Weilin, Wang, Wei
Publicado 2021

Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines

por Zhou, Weilin, Wang, Wei
Publicado 2021

Chimeric antigen receptor engineered natural killer cells for cancer therapy

por Zhang, Yalan, Zhou, Weilin, Yang, Jiangping, Yang, Jinrong, Wang, Wei
Publicado 2023

Current landscape of gene‐editing technology in biomedicine: Applications, advantages, challenges, and perspectives

por Zhou, Weilin, Yang, Jinrong, Zhang, Yalan, Hu, Xiaoyi, Wang, Wei
Publicado 2022

Recent Progress of Switching Power Management for Triboelectric Nanogenerators

por Zhou, Han, Liu, Guoxu, Zeng, Jianhua, Dai, Yiming, Zhou, Weilin, Xiao, Chongyong, Dang, Tianrui, Yu, Wenbo, Chen, Yuanfen, Zhang, Chi
Publicado 2022

Discovery of the first potent proteolysis targeting chimera (PROTAC) degrader of indoleamine 2,3-dioxygenase 1

por Hu, Mingxing, Zhou, Weilin, Wang, Yijie, Yao, Dongping, Ye, Tinghong, Yao, Yuqin, Chen, Bin, Liu, Gongping, Yang, Xifei, Wang, Wei, Xie, Yongmei
Publicado 2020

EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors

por Li, Dan, Guo, Xianling, Yang, Kun, Yang, Yuening, Zhou, Weilin, Huang, Yong, Liang, Xiao, Su, Jinhua, Jiang, Lin, Li, Jing, Fu, Maorong, He, Haixia, Yang, Jinrong, Shi, Huashan, Yang, Hanshuo, Tong, Aiping, Chen, Nianyong, Hu, Jiankun, Xu, Qing, Wei, Yu-Quan, Wang, Wei
Publicado 2023